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INTRODUCTION
Angiostrongylus vasorum (A. vasorum) is a red
thread-like metastrongyloid nematode (13-25 mm) liv-
ing in the pulmonary vessels and the right side of the
heart of canids. The natural end host is the common fox
(Vulpes vulpes), but other species, including domestic
dogs, can be infected. Other members of the An-
giostrongylus family include A. cantonensis and A.
costaricensis, which use rats as definitive hosts, al-
though A. cantonensis can also cause disease in dogs.
The uptake of the third stage larvae of A. cantonensis
or A.costaricensis in contaminated water or food by hu-
mans (accidental definitive host) causes eosinophilic
meningitis or intestinal granulomas (Wang et al., 2008;
Helm et al., 2010).
Dogs infected with A. vasorum can display an array
of clinical signs, including cardiopulmonary abnor-
malities, coagulation problems, neurological signs and
general malaise. The nickname ‘French heartworm’
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ABSTRACT
The French heartworm Angiostrongylus vasorum is a parasitic nematode that lives in the pulmonary vessels
and the heart of canids. Transmission occurs through ingestion of infected intermediate hosts, such as snails
and slugs. There are increasing reports of autochthonous infections in our neighbouring countries. Clinical
signs usually relate to the respiratory system, coagulopathy and the neurologic system. Anorexia,
gastrointestinal dysfunction and weight loss are also frequently observed. Diagnosis is not straightforward, but
abnormalities detected by thoracic radiography, echocardiography, magnetic resonance imaging (MRI) or
computed tomography (CT) scan can be helpful. Eosinophilia, regenerative anemia and thrombocytopenia
with or without abnormalities in the coagulation profile can occur. Definitive diagnosis is made by
demonstrating the parasite in the cerebrospinal fluid, in faeces (Baermann technique) and/or in broncho-
alveolar lavage fluid. Treatment consists of anthelmintic drugs and supportive care if necessary. 
SAMENVATTING
Angiostrongylus vasorum of de ‘Franse hartworm’ is een nematode die leeft in de longbloedvaten en het hart van
hondachtigen. Honden worden besmet door de opname van geïnfesteerde slakken, die als tussengastheer fungeren.
Er zijn steeds meer meldingen van autochtone infecties in de ons omringende landen. De symptomen bestaan
voornamelijk uit respiratoire, neurologische en bloedingsstoornissen. Ook anorexie, gastro-intestinale problemen en
gewichtsverlies worden gezien. De diagnose is niet eenvoudig maar thoraxradiografie, echocardiografie, MRI en
CT-scan kunnen een hulp zijn. Eosinofilie, regeneratieve anemie en trombocytopenie, al dan niet in combinatie met
abnormale stollingstijden, kunnen eveneens voorkomen. De definitieve diagnose wordt gesteld door het aantonen van
de parasiet in cerebrospinaal vocht, feces (met de baermanntechniek) en/of in broncho-alveolaire spoelvloeistof. De
behandeling bestaat uit een ondersteunende therapie en een toediening van antiparasitaire middelen.
finds its origin in the discovery and endemic presence
of the parasite in France. Today, however, the endemic
regions have expanded over the (sub)tropical and tem-
perate regions of Europe, Africa and North and South
America (Conboy, 2009; Helm et al., 2010). To the best
of our knowledge, an indigenous case of an-
giostrongylosis has not yet been reported in Belgium.
However, the parasite has been reported in all countries
surrounding Belgium. In the following article, we fo-
cus on the biology of the parasite and the clinical pres-
entation, diagnosis, treatment and prognosis of this
condition.
LIFE CYCLE AND EPIDEMIOLOGY
Life cycle
The indirect life cycle (Figure 1) of A. vasorum has
an essential developmental phase in an intermediate
(several species of slugs and snails) or paratenic host,
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for example frogs. The term paratenic hosts is used to
describe hosts which are not necessary in the life cy-
cle of a parasite but nonetheless can serve as a source
of infection for other hosts. They are also referred to
as transfer or transport hosts (Wang et al., 2008) (Bolt
et al., 1993). First stage larvae (L1) mature and moult
in the intermediate hosts into infective L3 larvae (L3).
The ingestion of infected intermediate or paratenic
hosts results in the infection of the definitive host. The
infection of the definitive host can also be caused by
the ingestion of free-living L3 because L3 can leave
the intermediate host and survive in water or on wet
grass. The importance of this latter infection route
has not yet been investigated in vivo (Barçante et al.,
2003; Denk et al., 2009). Once inside the small intes-
tine, the L3 penetrate the intestinal wall and migrate to
the abdominal lymph nodes where the third and fourth
moults take place. L5 larvae migrate through the lym-
phatics to the portal and hepatic veins and reach the
right ventricle and pulmonary arteries, where they de-
velop into adult worms. Female worms produce eggs
that are carried to the lung capillaries, where embry-
onation takes place. L1 larvae penetrate the bronchial
walls and alveoli and are coughed up and swallowed
by the host. They are excreted with the faeces where
they can survive for some days. After a long and va-
riable prepatent period (28-108 days), dogs can excrete
larvae for several years. Oliveira-Junior et al. (2006)
showed that experimentally infected dogs could ex-
crete larvae for more than 600 days, and they conclu-
ded that dogs are an important reservoir for infection,
even in an urban environment. 
Signalment
All dog breeds and ages can be infected as long as
they scavenge outside, although young dogs seem to be
predisposed to clinical infection. In the ‘Copenhagen
Angiostrongylus Survey’ (CAS), more than 50% of
the infected dogs were younger than one year (Koch
and Willesen, 2009), and in the study of Chapman et al.
(2004), the clinically affected dogs, on average, were
only ten months old. The reasons for this age distribu-
tion are not completely clear, but the inquisitiveness
and scavenging behavior of these young dogs may be
of importance. Frequently playing with and eating
snails is a known risk factor. Moreover, the immune
system continues to develop until the age of one, ma-
king young animals more susceptible to clinical infec-
tion (Day, 2007). 
In the Danish survey, no breed predisposition was
reported, although others have found a higher occur-
rence in Cavalier King Charles spaniels, Staffordshire
Bull terriers (Chapman et al., 2004) and beagles (Con-
boy et al., 2004). The last author attributed this fact to
the use of this breed as a hunting dog. Dogs used for
hunting seem to be more at risk because of their expo-
sure to infection from the fox-snail life cycle during
training (Conboy et al., 2004).
Epidemiology
Several factors are important in the epidemiology of
Angiostrongylus infections, but their individual im-
portance is not yet clear.
Figure 1. Life cycle of Angiostrongylus vasorum (with courtsey of Bayer animal Health®). L1: first stage larvae; L3:
third stage larvae; L5: fifth stage larvae.
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Geographically, an expansion of the distribution of
the infection is suggested, although the majority of
the information on distribution originates from case re-
ports from Germany (Denk et al. 2009; Barutzki and
Schaper., 2009), the Netherlands (Van Doorn et al.,
2009), Denmark (Taubert et al., 2009), Canada (Con-
boy, 2004; Bourque et al., 2008) and the United King-
dom (Chapman et al. 2004, Yamakawa et al. 2009).
Persistently hyperendemic foci, with a region of spo-
radic cases around them, are described. The scattered
and local appearance of the parasite suggests a diffe-
rence in the microclimate in which the intermediate
host thrives to a greater or lesser extent (Morgan et al.,
2009). Climatic factors are indeed important because
slugs and snails thrive in wet and moderate climates.
Slugs in particular are sensitive to lower temperatures;
in cold conditions, they are less active and survive for
less time (Morgan et al., 2009). Climate change and the
resulting increase in warm, moist winters in northern
areas might contribute to the spread of infection. An-
other possible explanation is the influence of environ-
mental conditions on the survival of the free-living L3
larvae (Taubert et al., 2009). 
For the definitive hosts, the infection prevalence is
remarkably higher in foxes compared to  dogs (5-56%
in comparison to 1-9.8%, the higher figure in hunting
dogs in Denmark) (Barutzki and Schaper, 2009; Koch
and Willesen, 2009). Wild reservoir species may be re-
sponsible for an expansion of the disease, as foxes can
range over large distances and are increasingly present
in (peri)urban areas (Koch and Willisen, 2009). 
As a final contribution, we must note the increased
travelling and non-controlled transportation of dogs, as
this can result in a worldwide spreading of the infec-
tion (Jeffries et al., 2010).
PATHOGENESIS AND CLINICAL SIGNS
The clinical presentation and its severity are highly
variable, ranging from subclinical disease to sudden
death. Respiratory symptoms are frequently reported,
but neurologic signs and coagulopathy are also possi-
ble. Symptoms might already be chronic when animals
are diagnosed with the infection (Chapman et al.,
2004).
Dogs with respiratory disease present with a (chro-
nic) history of gagging, coughing, exercise intolerance
and tachy- or dyspnea with or without cyanosis. These
symptoms are caused by an interstitial pneumonia and
inflammation caused by migrating L1 or can also be
due to decompensated heart failure due to pulmonary
hypertension in more severe cases (Chapman et al.,
2004; Nicolle et al., 2006). An acute respiratory crisis
may occur and is frequently accompanied by lung
bleeding or a hemothorax (Sasanelli et al., 2008). 
A second manifestation of infection is bleeding ab-
normalities, which are mostly diagnosed in referral
practices. Many types of bleeding at any possible lo-
cation (petechiae and ecchymoses as well as extensive
hematomas and bleedings in abdominal and thoracic
cavities) may be seen and several parts of the coagu-
lation pathway can be disturbed. Prothrombin time
(PT), activated partial thromboplastin time (APPT)
and D-dimer levels may be elevated, and fibrinogen le-
vels may be low (Ramsey et al., 1996). It is assumed
that the presence of parasites activates coagulation and
clotting factors and that platelets areconsumed. This is
followed by intravascular fibrinolysis. Coagulation
pathways are activated in two ways, the intrinsic
pathway (by direct damage to the epithelium through
the deposition of immune complexes) and the extrin-
sic pathway (by the release of tissue factors from da-
maged tissue) (Bourque et al., 2008). Likewise, Koch
and Willesen (2009) described thrombocytopenia and
elevated D-dimer levels in 80% of the cases, which
may suggest a low-graded disseminated intravascular
coagulopathy (DIC). Other explanations for thrombo-
cytopenia are an autoimmune reaction with the for-
mation of antiplatelet antibodies or platelet elimination
by activated macrophages (Gould and McInnes, 1999).
An acquired deficiency in von Willebrand factor
(VWF) has been described in a case report of a dog af-
fected by angiostrongylosis (Whitley et al., 2005). In
cases of DIC in humans, a normal or even increased le-
vel of VWF has been observed. In veterinary medi-
cine, however, information concerning the VWF levels
in DIC cases is lacking. Whitley et al. (2005) propo-
sed an accelerated removal of the circulating VWF as
an explanation for the lower VWF levels. The me-
chanism includes specific or non-specific antibodies
forming complexes with VWF and the removal by Fc-
receptor bearing cells. In general, one should always
consider angiostrongylosis in the differential diag-
nosis of bleeding problems in dogs living in endemic
areas (Chapman et al., 2004; Helm et al., 2010).
Bleeding in the brain or spinal cord can cause neu-
rologic symptoms. Craniotentorial bleeding can cause
epileptic seizures, paresis and abnormal postural reac-
tions (Wessman et al., 2009). In cases of cerebellar
bleeding, hypermetria, vestibular symptoms and opis-
thotonus are observed, and if the brainstem is affected,
abnormalities of the cranial nerves can be seen (Negrin
et al., 2008). As in humans infected with A. cantonen-
sis, inflammation has been postulated to be another po-
tential cause of these neurologic signs. Hypoxia and pa-
rasitic emboli can also cause neurologic symptoms
(Bourque et al., 2008).
Finally, uveitis, depression, weight loss, anorexia
and occasionally vomiting and diarrhoea are reported
(Koch and Willesen, 2009; Storms and Verdonck,
2011).
DIAGNOSIS
Clinical examination
Lung auscultation is usually normal, but in advanced
cases, crackles (in most cases generalized) can be de-
tected. With chronic pulmonary hypertension due to
larval thrombosis, a systolic murmur can be heard over
the tricuspid valve (Traversa and Guglielmini et al.,
2008). The exact position of the murmur can be varia-
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ble due to a shift in the location of the heart (Nicolle et
al., 2006).
Medical Imaging
Thoracic radiographs reveal most commonly a
multifocal/peripheral bronchointerstitial pattern with
alveolar patches (Willesen et al., 2009). When the dis-
ease progresses, an alveolar pattern at the periphery of
the lungs appears. This is likely due to the formation
of granulomas and the bleeding caused by the migra-
tion of L1 larvae (Helm et al., 2010). In the more
chronic stage, an interstitial pattern occurs that is cau-
sed by pulmonary consolidation and lung fibrosis.
After resolution of the infection, a mild interstitial pat-
tern can remain visible. Other abnormalities that can
be seen are right-sided heart enlargement, dilatation of
the truncus pulmonalis and, rarely, a rather eminent
appearance of the pulmonary vessels. Pleural effusion
(hemothorax) and a broadening of the mediastinum
can also be present (Traversa and Guglielmini, 2008;
Boag et al., 2004). 
High resolution computed tomography can also
contribute to a more accurate evaluation of the lung le-
sions. Consolidation in the periphery of lung lobes
(especially the caudal lobes) and a patchy multifocal
opacity can be seen. In severe cases, a general diffuse
attenuation throughout the entire lung can occur due to
the infiltration of inflammatory cells (Koch and Wil-
lesen, 2009; Helm et al., 2010).
In patients manifesting neurological signs, magne-
tic resonance imaging or myelography are useful diag-
nostic tools. In myelography, intramedullary contrast
accumulation similar to that seen in myelomalacia has
been reported (Wessmann et al., 2006). However, the
most sensitive method to detect intracranial and intra-
medullary bleeding is MRI. The exact appearance of
the bleeding depends on the chronicity of the lesion.
Although in theory it should be possible to visualize the
adult parasites, they have never been reported, and the
chance of observing a sufficiently long section of a pa-
rasite to make identification possible, is rather small
(Whitley et al., 2005).
Cardiac ultrasonography and Doppler are standard
methods for the evaluation of heart morphology and
function. Right atrial and right ventricular dilatations in
combination with a diminution of the left ventricle size,
change in the pulmonary flow profile (pulmonary arte-
rial hypertension or PAH) and secondary regurgitation
over the pulmonalis/tricuspidalis valve can be seen (Ni-
colle et al., 2006). The occurrence of PAH in dogs af-
fected with angiostrongylosis is estimated to be less
than 5% in first-line practice but can increase to more
than 33% in referral hospitals (Koch and Willisen, 2009).
The abnormalities mentioned above are not always pre-
sent nor are they specific for Angiostrongylosis. 
Blood and cerebrospinal fluid (CSF) analysis
Abnormalities on routine hematology are variable
and depend on the chronicity and severity of the in-
fection. Regenerative anemia (due to blood loss),
eosinophilia, thrombocytopenia and, less frequently,
leucocytosis and neutrophilia can be observed. The
fact that these findings normalize after treatment sup-
ports the hypothesis that a low-graded immune reac-
tion/response occurs in every dog infected with Angi-
ostrongylus (Chapman et al., 2004, Willesen et al.,
2009). 
Blood biochemistry can reveal an increased serum
total protein concentration, alkaline phosphatase (AP)
activity, globulin, bilirubin, cholesterol and fructosa-
mine concentrations (Chapman et al., 2004; Willesen
et al., 2009). Other authors, however, did not find sig-
nificant differences in experimentally infected dogs
for serum alanine aminotransferase (ALT), gamma-
glutamyl transferase (GGT) and AP activities for urea
and creatinine concentrations but did report an in-
crease in α1-, α2- and β-globuline concentrations in the
acute phase of infection (Cury et al., 2005). In experi-
mental infections, serum aspartate aminotransferase
(AST) concentrations increased slightly but not signi-
ficantly. The rise of AST occurred simultaneously with
creatine kinase isoenzyme MB (CK-MB). This en-
zyme is an indicator of heart damage, and its increase
runs parallel to the arrival of the parasite in the heart
(Cury et al., 2005).
In cases with bleeding problems, a prolongation of
coagulation times with or without thrombocytopenia
and other signs of DIC can be observed. Whitley et al.
(2005) reported a prolongation of the buccal mucosal
bleeding time (BMBT) and a decreased level of VWF.
After the administration of desmopressin, the BMBT
normalized, and after treatment of angiostrongylosis,
VWF also normalized.
Examination of CSF is often indicated in animals
showing neurological signs. An abnormally high pro-
tein content, signs of erythrophagia and high red blood
cell counts in combination with normal white blood
cell counts are typical findings in dogs with bleeding
in the central nervous system (Wessmann et al., 2006).
Faecal examination
A. vasorum L1 larvae can be detected in faecal
samples. L1 larvae (334-380 µm) are recognized by the
morphology of their tails (Figure 2). They have a ty-
pical indentation of the cuticle and a bulging at the dor-
sal surface of the tail called a dorsal notch and a dor-
sal spine, respectively. A smaller ventral indentation
can also be seen (Deplazes, 2006; Bourque et al., 2008;
McGary and Morgan, 2009).
Faecal samples can be examined by faecal smear, a
flotation technique or the Baermann technique. In urgent
cases, an attempt to diagnose the disease can be made
using a direct faecal smear for which a sensitivity of 54-
61% has been reported (Humm and Adamantos, 2010).
However, the Baermann method is considered the gold
standard for the definitive diagnosis of angiostrongylo-
sis. Nevertheless, the Baermann technique also has li-
mitations. Fresh samples are required because the larvae
need to migrate through a mesh wire. This is followed
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by passive sedimentation in the Baermann funnel,
which takes 24 to 36 hours and makes this test time
consuming. More importantly, several authors have
reported a negative Baermann test in dogs with angio-
strongylosis (Denk et al., 2008). During the long pre-
patent period, animals can display symptoms, but the
larvae cannot yet be detected in the faeces. Moreover,
the excretion of larvae is intermittent and variable.
For this reason, it is advisable to collect faecal samples
over a period of three consecutive days. A negative Ba-
ermann result does not exclude infection in a dog with
typical symptoms living in a high-risk environment
(Traversa and Guglielmini, 2008; Helm et al., 2010).
Bronchoalveolar lavage
Bronchoalveolar lavage (BAL) can be useful to
examine cells and material from the trachea and lungs.
When lesions are present in the lungs, the parasite can
be demonstrated together with an increase in neutro-
phils, eosinophils and giant polynuclear cells (Bar-
çante et al., 2008). The disadvantages of this technique
are the potential risks, the associated morbidity (cough
and crackles), the need for sedation/anesthesia and the
poor sample recovery (small volumes). Furthermore,
when there are no significant lesions in the lung, this
test will be negative (Chapman et al., 2004).
Serology and molecular techniques
Serologic testing has a few inherent problems, such
as cross reactivity between several endoparasites and
the lack of differentiation between past and current in-
fections. Nevertheless, there are some promising tests
that have been developed, but none are commercially
available. Verzberger-Epstein et al. (2008) developed a
sandwich ELISA for the detection of circulating antigen
in sera with a specificity of 100% (no cross reactivity
with Crenosoma vulpis) and a sensitivity of 98% (two
false negatives due to a low worm burden), which is a
better result than the Baermann test. Recently, Schny-
der et al. (2011) have developed a very sensitive
(95.7%) and specific (94%) sandwich ELISA for the
detection of circulating antigen. The authors believe
that this test is a valid alternative for the diagnosis, fol-
low-up and mass screening.  
Molecular testing has great potential but unfortu-
nately is currently only used in experimental models
and is not yet commercially available (Al-Sabi et al.,
2010). A real-time PCR assay has been developed
which is able to amplify a region of the second inter-
nal transcribed spacer (ITS-2) of A. vasorum in both
definitive host samples (200 µl EDTA canine blood as
well as 200 mg of canine faeces) and intermediate
host tissue (Jeffries et al., 2009). 
Necropsy findings
Affected lungs show granulomatous pneumonia with
suppurative and eosinophilic inflammation with vascu-
lar changes (thrombosis and fibrosis). Adult worms are
present in the pulmonary arteries and right heart and are
surrounded by fibrin. The reddish adult males are 14-18
mm in length and have a small bursa, two long spiculae
and a kinked tail. Females are larger (18-25 mm), with
a vulvar orifice just before the anus and long greyish
ovaria coiled around the red intestine. Larvae are found
in the smaller vessels of the lungs and cause inflamma-
tion. This causes the formation of caseogranulomas at
the periphery of the lungs and pleura (Bourque et al.,
2008; Denk et al. 2008; Koch and Willesen, 2009).
Aberrant migration of larvae can cause caseogranulomas
in other organs, such as the kidney, brain, spleen, adren-
als and tracheobroncheal lymph nodes (Bourque et al.,
2008). The occurrence of larvae in the urinary system,
the eye, pericardium, pancreas, liver, muscle and the
skin has also been reported (Perry et al., 1991; Oli-
viera-Junior et al., 2004). Myocarditis and glomerulo-
nephritis due to a type II hypersensitivity reaction and
aberrant larvae was the cause of death in one dog (Gould
and Mc Innes, 1999). In severe cases with extensive tis-
sue damage, smooth muscle hypertrophy and hyper-
plasia of the arterial tunica media can be seen, which
may be consequences of pulmonary hypertension. In
cases of bleeding problems, large hematomas can be
found, and if neurologic signs were present, bleeding in
the brain or spinal cord can be noticed (Garosi et al.,
2005, Bourque et al., 2008).
TREATMENT
The treatment consists of two parts: anthelmintic
therapy and supportive care. Supportive care depends
on the severity of the symptoms and consists of cage
rest and hospitalization with oxygen supplementa-
tion in severe respiratory cases. In cases with life
threatening DIC or bleeding problems, transfusions
with blood, fresh frozen plasma or packed red blood
cells may be life saving. Bleeding problems tend to re-
solve 24 hours after anthelmintic treatment, but the
exact mechanism of the resolution of the bleeding pro-
Figure 2. First stage larva (L1) visualized by light micro-
scopy, the kinked tail with dorsal notch is the primary
diagnostic feature (with courtsey of Bayer animal
Health®). 
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blems is not yet clear (Koch and Willesen, 2009). The
use of other medications (e.g., corticosteroids, bron-
chodilators, diuretics, and ACE-inhibitors) is anecdo-
tal and depends on the assessment of the clinician
(Chapman et al., 2004). Corticosteroids can be helpful
in anaphylactic reactions and immune-mediated throm-
bocytopenia and can reduce pulmonary inflammation
and secondary fibrosis (Gould and McInnes, 1999;
Koch and Willesen, 2009).
The use of various anthelmintics has been described
in the literature, among which fenbendazole, milbe-
mycin oxime and imidacloprid/moxidectin spot-on are
the most frequently used (Table 1). The treatment with
ivermectin and levamisole may have side effects. Ana-
phylactic reactions due to the rapid killing of parasites
have been described after levamisole treatment (Bour-
que et al., 2008). Fenbendazole, milbemycin oxime and
moxidectin/imidacloprid act more slowly, thereby re-
ducing the chance of adverse reactions. There is no dif-
ference in efficacy between fenbendazole (25 mg/kg,
SID for 20 days) and imidacloprid 10%/moxidectin
2.5% (single topical dose of 0.1 ml/kg). However, fen-
bendazole is not registered for this use in Europe
(Gould and McInnes, 1999; Conboy, 2004). Imidaclo-
prid 10%/moxidectin 2.5% (single topical dose of 0.1
ml/kg) efficiently eliminates L4 stages and immature
adults and side effects are rare (Willesen et al., 2007;
Schnyder et al., 2009). Milbemycin oxime (0.5 mg/kg
p.o.) is also efficient in eliminating infection when
used once a week for four weeks (Conboy, 2004).
Six weeks after the treatment with moxidectin/imi-
dacloprid and three weeks after the fenbendazole treat-
ment, a Baermann test should be performed on a
pooled sample from faeces collected on three conse-
cutive days. The test should confirm cure and exclude
the conversion to an asymptomatic carrier status be-
cause these carriers can act as a reservoir for infection
(Chapman et al., 2004, Willesen et al., 2007). In en-
demic areas, reinfections can occur, and as a conse-
quence, regular testing (every three to six months) is
advisable (Koch and Willesen, 2009). 
PROGNOSIS
The majority of the dogs infected with Angiostron-
gylus have an uneventful recovery, although this is
dependent on the severity of the symptoms. Respiratory
symptoms disappear within 1-2 weeks, but coughing
can resolve earlier. In 40% of the severe cases, residual
symptoms (cough and exercise intolerance) can occur
after the elimination of the infection. An early diagnosis
and treatment should help to avoid this. When PAH oc-
curs, the prognosis depends on the severity of the in-
fection (Koch and Willesen, 2009). 
Dogs displaying neurologic signs have a good long-
term prognosis independent of the symptoms caused by
bleeding or inflammation (Garosi et al., 2005; Negrin
et al., 2008).
If mortality occurs, it is usually caused by severe
(non-compensated) bleeding or respiratory failure. In
referral hospitals, mortality rates of 10-15% have been
reported (Chapman et al., 2004; Koch and Willesen,
2009).
PROPHYLAXIS
Imidacloprid 10%/moxidectin 2.5% has been pro-
ven effective and is currently licensed for prophylac-
tic use against Angiostrongylus (Schnyder et al., 2009;
Schnyder et al., 2011). In hyperendemic regions, how-
ever, veterinarians should educate owners about the cli-
nical symptoms and possible risks. They can advise re-
moving their dogs’ faeces and trying to avoid the intake
of slugs and snails by putting the dog on a leash. The
removal of snails is virtually impossible and ecologi-
cally not recommended (Helm et al., 2010). 
CONCLUSION
Because of the emerging occurrence of A. vasorum
in our neighboring countries, it should be included in
the differential diagnosis of all cases presented with
unexplained bleeding tendencies, respiratory and/or
neurologic signs. Unfortunately, the diagnosis is not
Table 1. Frequently used drugs in the treatment of Angiostrongylus vasorum and their dosage (adapted from Helm et
al., 2010).
Drug Dose
Fenbendazole 1) 20-25 mg/kg PO SID for 20 days
2) 50 mg/kg PO SID for 5-21 days
Imidacloprid/ Moxidectin topical 0,1 ml/kg single dose
Milbemycin oxime 0,5 mg/kg PO once a week during 4 weeks 
Levamisole 1) 7,5 mg/kg PO SID for 2 days
then 10 mg/kg for 2 days
2) 12,5 mg/kg SC for 3 days
Ivermectin 200-400 µg/kg SC every 3 weeks
2-4 treatments
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straightforward, and the Baermann testing of mixed
faecal samples is still the gold standard. However,
once the diagnosis is established, the treatment is ra-
ther simple with commercially available anthelmintic
products. Clinicians’ awareness of this illness and its
various clinical signs is important because full reco-
very is possible if diagnosed at an early disease stage.
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